市场调查报告书
商品编码
1446183
2024-2028年全球高性能生物材料市场Global High Performance Biomaterials Market 2024-2028 |
高性能生物材料市场预计在 2023-2028 年期间成长 84.8 亿美元,预测期内复合年增长率为 11.29%。
该报告包括对高性能生物材料市场的总体分析、市场规模和预测、趋势、成长动力、挑战以及涵盖约 25 家供应商的供应商分析。
它提供了对当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。该市场的驱动因素包括肌肉骨骼疾病和病症的盛行率不断上升、牙科疾病和相关风险因素的盛行率不断上升,以及全关节重建和关节置换术的激增。
市场范围 | |
---|---|
基准年 | 2024年 |
结束年份 | 2028年 |
预测期 | 2024-2028 |
成长动力 | 加速度 |
2024年与前一年同期比较 | 10.21% |
复合年增长率 | 11.29% |
增量 | 84.8亿美元 |
这项研究将组织工程中高性能生物材料的发展视为未来几年推动高性能生物材料市场成长的关键因素之一。此外,再生医学的先进研究和药物传输系统的进步也将带来巨大的市场需求。
The high performance biomaterials market is forecasted to grow by USD 8.48 bn during 2023-2028, accelerating at a CAGR of 11.29% during the forecast period. The report on the high performance biomaterials market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of musculoskeletal diseases and disorders, rising prevalence of dental diseases and related risk factors, and surging number of joint replacement and arthroplasty surgeries.
Technavio's high performance biomaterials market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 10.21% |
CAGR | 11.29% |
Incremental Value | $8.48bn |
By Type
By Application
By Geographical Landscape
This study identifies the development of high-performance biomaterials in tissue engineering as one of the prime reasons driving the high performance biomaterials market growth during the next few years. Also, progressive research on regenerative medicine and advancements in drug delivery systems will lead to sizable demand in the market.
The report on the high performance biomaterials market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading high performance biomaterials market vendors that include Advanced Medical Solutions Group Plc, Arctic Biomaterials Oy Ltd, BASF SE, Berkeley Advanced Biomaterials, CAM Bioceramics BV, CoorsTek Inc., Corbion nv, Covestro AG, Dentsply Sirona Inc., Evonik Industries AG, Himed LLC, Honeywell International Inc., Koninklijke DSM NV, Regenity Biosciences, RevBio Inc., Solesis, Stryker Corp., Victrex Plc, Zimmer Biomet Holdings Inc., and ZimVie Inc.. Also, the high performance biomaterials market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: